Fractyl Labs Announces Approval to Initiate Multicenter Clinical Trial of Revita DMR Procedure
January 12, 2015Fractyl Labs receives approval to begin enrollment in a clinical trial to evaluate Revita™ Duodenal Mucosal Resurfacing™ (DMR) procedure, the first procedural therapy designed to teat insulin resistance in patients with uncontrolled type 2 diabetes.
More »
Tandem Diabetes Care Announces FDA Clearance of the t:flex™ Insulin Pump
January 12, 2015FDA grants Tandem Diabetes Care clearance to market the t:flex™ Insulin Pump. The pump is designed for patients with greater insulin needs such as teenagers with type 1 diabetes and many people with type 2 diabetes.
More »
Dicerna Pharmaceuticals Presents Positive Preclinical Data on its DsiRNA Therapeutics Targeting MYC and β-Catenin at AACR MYC: From Biology to Therapy Meeting
January 12, 2015Dicerna Pharmaceuticals will present new preclinical data on its Dicer substrate short interfering RNA therapeutics targeting oncogenes in cancer models on Jan. 9th at MYC: From Biology to Therapy, an American Association of Cancer Research (AACR) meeting
More »